The pharmaceutical industry in India is growing at 12–15% annually, and the cardiac-diabetic segment is growing at an astonishing 22–25% CAGR. Within this segment, Cardiac Diabetic PCD Pharma Franchise in Bihar has emerged as one of the most lucrative and sustainable business models in Eastern India in 2025–2030.
With a population exceeding 13 crore, low market penetration in Tier-2 & Tier-3 cities, and rapidly increasing lifestyle disorders, Bihar offers a goldmine for entrepreneurs willing to enter the cardio-diabetic pharma distribution business.
Fact: As of November 2025, the cardiac & diabetic medicine market size in Bihar alone is estimated to cross ₹2,800 crore, and less than 40% of this market is currently organized. This means whoever enters now with the right company and strategy will dominate for the next decade.Bihar has transformed dramatically in the last 5–7 years. Better roads, electricity, internet penetration, and rising disposable income have completely changed the healthcare-seeking behavior of people.
All these factors combined have created a perfect storm of opportunity for anyone starting a Cardiac Diabetic PCD Pharma Franchise in Bihar today.
Oidrac Remedies is a WHO-GMP, GLP & ISO 9001:2015 certified pharmaceutical company headquartered with ultra-modern manufacturing plants in the excise-free zone. We specialize exclusively in cardiac, diabetic, and critical care segments with more than 80+ DCGI-approved formulations.
| Category | Examples (Partial List) | Pack |
|---|---|---|
| Anti-Hypertensives | Telmisartan 40/80, Amlodipine + Atenolol, Nebivolol + S-Amlodipine, Cilnidipine + Metoprolol | 10×10 Alu-Alu |
| Oral Anti-Diabetics | Teneligliptin 20, Dapagliflozin 10, Vildagliptin + Metformin, Sitagliptin + Metformin, Glimepiride + Metformin + Voglibose | 10×10 / 10×1×15 |
| Injectables (Cardiac) | Enoxaparin 40/60 mg PFS, Nadroparin, Tirofiban, Dopamine, Dobutamine, Noradrenaline | Single PFS |
| Lipid Lowering Agents | Rosuvastatin + Fenofibrate, Atorvastatin + Ezetimibe, Pitavastatin | 10×10 |
| Anti-Platelet & Anti-Coagulants | Clopidogrel + Aspirin, Ticagrelor 90, Prasugrel, Apixaban 2.5/5, Rivaroxaban 20 | 10×10 |
| Cardiac Supplements | Coenzyme Q10 + L-Carnitine + Lycopene, Omega-3 + Vitamin E | 10×1×10 Softgel |
| Diabetic Neuropathy Range | Pregabalin + Nortriptyline, Methylcobalamin + Alpha Lipoic Acid + Benfotiamine | 10×10 |
We keep adding latest combinations every quarter so our franchise partners never run out of new prescriptions.
We are offering exclusive district-wise monopoly in the following locations :
| Particular | Amount (₹) |
|---|---|
| Initial Stock Purchase | 1,50,000 – 4,00,000 |
| Drug License & GST (one time) | 10,000 – 15,000 |
| Promotional Material (Free from company) | 0 |
| Monthly Working Capital | 1,00,000 – 2,00,000 |
| Average Monthly Billing (6th month onwards) | 8–18 lakh |
| Average Net Profit Margin | 38–52% |
| Expected ROI in First Year | 300–500% |
None. We provide complete training. Even fresh graduates are earning ₹80,000+ net profit per month within 6 months.
Yes. Only one distributor per district. No second appointment ever.
No penalty. Targets are only for bonus & trip qualification.
Yes. We encourage multi-company portfolio.
Advance payment for first 3 orders, then 15–30 days credit after relationship builds.
The next 5 years belong to those who enter the Cardiac Diabetic PCD Pharma Franchise in Bihar right now. With Oidrac Remedies as your partner, you get not just products, but a complete business ecosystem that guarantees growth, stability and wealth creation.